ARK GENOMIC REVOLUTION MULTI SECTOR ETF (ARKG) HOLDINGS

As of 12/10/2020

Company Ticker CUSIP Shares Market Value($) Weight(%)

1 CRISPR THERAPEUTICS AG CRSP H17182108 3,155,453 486,760,179.78 8.47

2 PACIFIC BIOSCIENCES OF CALIF PACB 69404D108 20,016,038 439,151,873.72 7.65
3 ARCTURUS THERAPEUTICS HOLDIN ARCT UQ 03969T109 3,842,489 405,190,465.05 7.05
4 INVITAE CORP NVTA 46185L103 6,195,551 355,624,627.40 6.19
5 TWIST BIOSCIENCE CORP TWST 90184D100 2,296,092 349,465,202.40 6.08
6 PERSONALIS INC PSNL 71535D106 5,450,145 213,591,182.55 3.72
7 FATE THERAPEUTICS INC FATE 31189P102 2,178,331 210,971,357.35 3.67
8 CAREDX INC CDNA 14167L103 2,901,498 205,048,863.66 3.57
9 TELADOC HEALTH INC TDOC 87918A105 1,016,431 202,279,933.31 3.52
10 IOVANCE BIOTHERAPEUTICS INC IOVA 462260100 4,054,501 200,616,709.48 3.49
11 EXACT SCIENCES CORP EXAS 30063P105 1,382,145 183,673,249.05 3.20
12 CELLECTIS - ADR CLLS 15117K103 6,051,067 182,863,244.74 3.18
13 EDITAS MEDICINE INC EDIT 28106W103 2,022,952 135,214,111.68 2.35
14 PURE STORAGE INC - CLASS A PSTG 74624M102 6,146,439 134,238,227.76 2.34
15 MORGAN STANLEY GOVT INSTL 8035 X9USDMORS 126,889,965 126,889,964.75 2.21
16 VERACYTE INC VCYT 92337F107 2,196,542 125,466,479.04 2.18
17 INTELLIA THERAPEUTICS INC NTLA 45826J105 2,184,178 122,008,183.08 2.12
18 ACCOLADE INC ACCD 00437E102 1,682,560 100,482,483.20 1.75
19 INCYTE CORP INCY 45337C102 1,165,606 95,637,972.30 1.66
20 SERES THERAPEUTICS INC MCRB 81750R102 3,561,614 89,182,814.56 1.55
21 BERKELEY LIGHTS INC BLI 084310101 944,019 84,961,710.00 1.48
22 VERTEX PHARMACEUTICALS INC VRTX 92532F100 373,292 83,632,339.68 1.46
23 TAKEDA PHARMACEUTIC-SP ADR TAK UN 874060205 4,387,494 82,397,137.32 1.43
24 COMPUGEN LTD CGEN M25722105 5,735,230 71,575,670.40 1.25
25 NOVARTIS AG-SPONSORED ADR NVS 66987V109 734,175 67,309,164.00 1.17
26 CASTLE BIOSCIENCES INC CSTL 14843C105 1,126,321 66,633,150.36 1.16
27 REGENERON PHARMACEUTICALS REGN 75886F107 135,862 65,075,180.76 1.13
28 CERUS CORP CERS 157085101 8,174,256 63,595,711.68 1.11
29 ADAPTIVE BIOTECHNOLOGIES ADPT 00650F109 1,098,118 60,649,057.14 1.06
30 IONIS PHARMACEUTICALS INC IONS 462222100 1,307,006 60,618,938.28 1.06
31 SCHRODINGER INC SDGR 80810D103 848,285 57,624,000.05 1.00
32 10X GENOMICS INC-CLASS A TXG 88025U109 378,910 56,631,888.60 0.99
33 ALPHABET INC-CL A GOOGL 02079K305 32,126 56,787,523.90 0.99
34 BEAM THERAPEUTICS INC BEAM 07373V105 704,851 54,625,952.50 0.95
35 ROCHE HOLDINGS LTD-SPONS ADR RHHBY 771195104 1,228,439 53,043,996.02 0.92
36 PHREESIA INC PHR 71944F106 935,361 52,716,945.96 0.92
37 THERMO FISHER SCIENTIFIC INC TMO 883556102 106,076 49,722,064.24 0.87
38 NANOSTRING TECHNOLOGIES INC NSTG 63009R109 724,508 49,049,191.60 0.85
39 GUARDANT HEALTH INC GH 40131M109 383,920 48,396,955.20 0.84
40 AQUABOUNTY TECHNOLOGIES AQB 03842K200 6,337,349 44,361,443.00 0.77
41 CODEXIS INC CDXS 192005106 2,316,671 40,912,409.86 0.71
42 SYROS PHARMACEUTICALS INC SYRS 87184Q107 3,167,084 32,430,940.16 0.56
43 EVOGENE LTD EVGN M4119S104 4,594,499 19,802,290.69 0.34
44 PLURISTEM THERAPEUTICS INC PSTI 72940R300 2,706,680 16,835,549.60 0.29
45 REPARE THERAPEUTICS INC RPTX 760273102 427,705 15,842,193.20 0.28
46 LONGVIEW ACQUISITION CORP-A LGVW 543195101 847,317 13,057,154.97 0.23
47 SURFACE ONCOLOGY INC SURF 86877M209 745,641 7,217,804.88 0.13
48 ORGANOVO HOLDINGS INC ONVO 68620A203 375,102 2,865,779.28 0.05
49 SAREPTA THERAPEUTICS INC SRPT 803607100 7,321 1,171,360.00 0.02

The principal risks of investing in ARK ETFs include equity, market, management and non-diversification risks, as well as fluctuations in market
value and net asset value ("NAV"). Investors should carefully consider the investment objectives and risks as well as charges and expenses of
an ETF before investing. This and other information are contained in each ETF's prospectus, which may be obtained by contacting the ETF's
transfer agent The Bank of New York Mellon or by clicking here. Please read the prospectus carefully before you invest.
The market price of ETF shares may differ significantly from their NAV during periods of market volatility. ETF shares may only be redeemed
directly with the ETF at NAV by Authorized Participants, in very large creation units.
Holdings are subject to change without notice and are not a recommendation to buy or sell any security.
There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain
unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur
brokerage costs that detract significantly from investment returns.
©2020, ARK Investment Management LLC. All content is original and has been researched and produced by ARK Investment Management LLC
unless otherwise stated. No part of this content may be reproduced in any form, or referred to in any other publication, without the express
written permission of ARK Investment Management LLC. All statements made regarding companies, securities or other financial information on
this site or any sites or articles relating to ARK Investment Management LLC are strictly beliefs and points of view held by ARK Investment
Management and are subject to change without notice. Information contained herein has been obtained from sources believed to be reliable, but
not guaranteed. This material has been distributed for informational purposes only and should not be considered as investment advice or a
recommendation of any particular security, strategy or investment product.